Alliance Pharma

Alliance Pharma PLC is a United Kingdom-based pharmaceutical company. It owns the rights to more than 90 pharmaceutical and consumer health care products whom it markets through a network of partner companies in more than 100 countries.
 

Alliance Pharma has products in cardiology, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynaecology, oral health, oncology, stoma care, toxicology and travel health.
 

Alliance Pharma business model is to acquire proven pharmaceutical and consumer health assets  – developing and marketing them through their global network of partners in order to fully realise their value.    Alliance Pharma has a rigorous process to screen and identify high potential acquisition targets.    It uses the same rigor to find the optimum partner for these assets.    This often results in Alliance Pharma working with more than one partner in each country.      
    

Aenon Pharmaceuticals is pleased to represent Alliance Pharma star product KELO-COTE in Singapore.    KELO-COTE is a clinically proven prevention and treatment for hypertrophic and keloid scars.     

For more information on Kelo-cote, CLICK HERE